The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?

Andreas Carus*, Karin Holmsten, Helle Pappot, Anders Ullén

*Corresponding author for this work
Original languageEnglish
JournalActa Oncologica
Volume61
Issue number12
Pages (from-to)1515-1516
Number of pages2
ISSN0284-186X
DOIs
Publication statusPublished - Dec 2022

Keywords

  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Chemotherapy, Adjuvant
  • Cisplatin/therapeutic use
  • Humans
  • Muscles
  • Neoadjuvant Therapy
  • Neoplasm Invasiveness
  • Treatment Outcome
  • Urinary Bladder Neoplasms/drug therapy

Cite this